VinUni Banner

Experiment Filter

Therapeutic Area
Study Status
Phase

Experiment list

Experiments matching your search: 10

Evaluating the efficacy and safety of transarterial chemoembolization (TACE) in combination with immunotherapy and targeted therapy versus TACE alone in patients with regionally localized hepatocellular carcinoma
View more
Deadline 17 Apr 2026
Time Phase 3
House Completed
House Liver Cancer
Assessing the efficacy and safety of a novel targeted therapy in patients with metastatic hormone-sensitive prostate cancer (mHSPC) with PTEN loss
View more
Deadline 23 Apr 2026
Time Phase 3
House Ongoing
House Prostate cancer
A study evaluating the effect on lung function of an approved COPD treatment – a metered-dose inhaler using HFA propellant versus a metered-dose inhaler using a new HFO propellant
View more
Deadline 23 Apr 2026
Time Phase 3
House Completed
House COPD
Randomized, controlled, blinded clinical trial to evaluate the safety, immunogenicity and efficacy of the self-amplifying RNA vaccine ARCT-154 for prevention of SARS-CoV-2 infection in adults
View more
Deadline 27 Apr 2026
Time Phase 1
House Completed
House
Evaluating the safety and efficacy of a new biologic targeted therapy versus placebo, as add-on to standard treatment, in adults with chronic obstructive pulmonary disease (COPD) with symptoms and a history of exacerbations
View more
Deadline 28 Apr 2026
Time Phase 1
House Ongoing
House COPD
Evaluating the safety and efficacy of a new biologic targeted therapy versus placebo, as add-on to standard treatment, in adults with idiopathic inflammatory myopathies (polymyositis and dermatomyositis)
View more
Deadline 29 Apr 2026
Time Phase 3
House Recruiting
House Polymyositis
CD19 CAR T-Cell Therapy for R/​R Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia
View more
Deadline 29 Apr 2026
Time Phase 1
House Completed
House Non-Hodgkin Lymphoma
Evaluating the efficacy of a new treatment regimen versus standard therapy on the risk of heart failure events and cardiovascular mortality in patients with heart failure and impaired renal function
View more
Deadline 30 Apr 2026
Time Phase 3
House Recruiting
House Heart failure
Evaluating the safety and efficacy of a new biologic targeted therapy versus placebo in adults with systemic sclerosis
View more
Deadline 15 Oct 2026
Time Phase 3
House Recruiting
House Systemic sclerosis
Assessing the efficacy and safety of dual targeted therapy in patients with advanced or metastatic NSCLC harboring EGFRm+ and MET+ alterations
View more
Deadline 31 Dec 2026
Time Phase 2
House Completed
House Lung cancer